PTBI Announces Initiation Of Enrollment Of MuGard® Trial For Afinitor®; IRWD Initiates Phase I Clinical Study Of IW-1973

PTBI, announced enrollment has begun in a clinical trial at UCLA's Jonsson Comprehensive Cancer Center. IRWD announced dosing has begun in a Phase I clinical study of IW-1973, the first clinical compound in a broad.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.